Cargando…

B cell-regulated immune responses in tumor models and cancer patients

The essential role played by T cells in anticancer immunity is widely accepted. The immunosuppressive functions of regulatory T cells are central for tumor progression and have been endowed with a robust predictive value. Increasing evidence indicates that also B cells have a crucial part in the reg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fremd, Carlo, Schuetz, Florian, Sohn, Christof, Beckhove, Philipp, Domschke, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782133/ https://www.ncbi.nlm.nih.gov/pubmed/24073382 http://dx.doi.org/10.4161/onci.25443

Ejemplares similares

Parity improves anti-tumor immunity in breast cancer patients
por: Krause, Anna-Lena, et al.
Publicado: (2017)

HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients
por: Schmidt, Hans-Henning, et al.
Publicado: (2013)

Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1
por: Rathinasamy, Anchana, et al.
Publicado: (2017)

Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistry
por: Stefanovic, Stefan, et al.
Publicado: (2017)

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial
por: von Au, Alexandra, et al.
Publicado: (2016)

Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020)

Acceptance of oral chemotherapy in breast cancer patients - a survey study
por: Schott, Sarah, et al.
Publicado: (2011)

Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer
por: Fischer, Chiara, et al.
Publicado: (2022)

Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer
por: Safi, Seyer, et al.
Publicado: (2020)

Adenoid cystic carcinoma of the salivary glands: a pilot study of potential therapeutic targets and characterization of the immunological tumor environment and angiogenesis
por: Michaelides, Ioannis, et al.
Publicado: (2023)

Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells
por: Dinkic, Christine, et al.
Publicado: (2017)

Molecular Subtype Conversion between Primary and Metastatic Breast Cancer Corresponding to the Dynamics of Apoptotic and Intact Circulating Tumor Cells
por: Stefanovic, Stefan, et al.
Publicado: (2019)

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients
por: Wallwiener, Markus, et al.
Publicado: (2014)

B cell regulation in cancer and anti-tumor immunity
por: Sarvaria, Anushruti, et al.
Publicado: (2017)

Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients
por: Xydia, Maria, et al.
Publicado: (2021)

A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial)
por: Safi, Seyer, et al.
Publicado: (2015)

Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses
por: Quandt, Jasmin, et al.
Publicado: (2018)

Evaluation of Virtual Touch Tissue Imaging Quantification, a New Shear Wave Velocity Imaging Method, for Breast Lesion Assessment by Ultrasound
por: Golatta, Michael, et al.
Publicado: (2014)

Exam preparatory course for the 2nd part of the German medical examination in obstetrics and gynecology – a potential tool for the recruitment of new residents during the occupational decision process before the practical year?
por: Riedel, Fabian, et al.
Publicado: (2019)

Low-density lipoprotein balances T cell metabolism and enhances response to anti-PD-1 blockade in a HCT116 spheroid model
por: Babl, Nathalie, et al.
Publicado: (2023)

A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer
por: Reissfelder, Christoph, et al.
Publicado: (2011)

Immune Response and the Tumor Microenvironment: How They Communicate to Regulate Gastric Cancer
por: Lee, Keunwook, et al.
Publicado: (2014)

mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment
por: Mafi, Sahar, et al.
Publicado: (2022)

A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer After Prior Trastuzumab and Pertuzumab
por: Fischer, Stefanie, et al.
Publicado: (2022)

Age-Dependent Hematologic Toxicity Profiles and Prognostic Serologic Markers in Postoperative Radiochemotherapy Treatment for Uterine Cervical Cancer
por: Meixner, Eva, et al.
Publicado: (2022)

CD83 Regulates the Immune Responses in Inflammatory Disorders
por: Riaz, Bushra, et al.
Publicado: (2023)

A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes
por: Khandelwal, Nisit, et al.
Publicado: (2015)

HER2-targeted therapy influences CTC status in metastatic breast cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020)

International Regensburg Center for Interventional Immunology (RCI) symposium on “Synthetic immunology and environment-adapted redirection of T cells”, 17–18 July, 2019, Regensburg, Germany
por: Beckhove, Philipp, et al.
Publicado: (2020)

Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer
por: Timke, Carmen, et al.
Publicado: (2011)

Tumor location impacts immune response in mouse models of colon cancer
por: Zhao, Xianda, et al.
Publicado: (2017)

Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice
por: Schneeweiss, Andreas, et al.
Publicado: (2019)

The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses
por: Gamez-Belmonte, Reyes, et al.
Publicado: (2020)

Training the Immune Response: B-cells' Master Regulator
Publicado: (2004)

Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma
por: Machiraju, Devayani, et al.
Publicado: (2023)

Germinal center hypoxia in tumor-draining lymph nodes negatively regulates tumor-induced humoral immune responses in mouse models of breast cancer
por: Firmino, Natalie S, et al.
Publicado: (2021)

Regulation of Antitumor Immune Responses by Exosomes Derived from Tumor and Immune Cells
por: Rincón-Riveros, Andrés, et al.
Publicado: (2021)

MicroRNAs Regulating Tumor Immune Response in the Prediction of the Outcome in Patients With Breast Cancer
por: Thomopoulou, Konstantina, et al.
Publicado: (2021)

Radiation-Induced Fibrotic Tumor Microenvironment Regulates Anti-Tumor Immune Response
por: Nam, Jae-Kyung, et al.
Publicado: (2021)

47461 Regulation of the immune response in the tumor microenvironment of lung adenocarcinoma
por: Simmons, Glenn
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_adaqfmnlv456vhp3k01j2p2gh7